COX4I1 and glioblastoma: The seemingly conflicting effects of COX4-1 overexpression on some metabolites within these pathways indicate the high degree of complexity involved, however, and point to the need for more intricate studies to fully understand how these pathways interact to promote GBM aggression and resistance to therapy.